| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,003 | 0,009 | 07:00 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| WESANA HEALTH Aktie jetzt für 0€ handeln | |||||
| 24.01.25 | Wesana Health Holdings Inc.: Wesana Health Announces Change to The Board of Directors | 852 | Newsfile | Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - January 24, 2025) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTC Pink: WSNAF) (the "Company") is pleased to announce the appointment of Mark... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,010 | -0,43 % | EILMELDUNG: Fresenius Medical Care-Aktie bricht ein - Panik greift um sich! | ||
| ESSILORLUXOTTICA | 275,50 | +1,10 % | UBS stuft EssilorLuxottica auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für EssilorLuxottica auf "Buy" mit einem Kursziel von 352 Euro belassen. Zuzanna Pusz rechnet in einer am Montag vorliegenden... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,078 | -8,82 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 146,85 | +2,76 % | Here's What to Expect From Align Technology's Next Earnings Report | ||
| NUGEN MEDICAL DEVICES | 0,021 | +2,97 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| HEALWELL AI | 0,537 | +1,61 % | Healwell AI Inc: Healwell AI comments on forward-looking Nov. 3 NR | ||
| INMODE | 12,300 | -8,24 % | InMode Q4 Preliminary Revenue Rises | ||
| ATOSSA THERAPEUTICS | 0,577 | +0,70 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer | SEATTLE, Jan. 6, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing innovative medicines for unmet... ► Artikel lesen | |
| SPINEWAY | 0,190 | +1,06 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| ELEVANCE HEALTH | 322,30 | +2,61 % | Elevance Health upgraded at Wolfe as Medicare Advantage a near-term driver | ||
| MOUNTAIN VALLEY MD | 0,007 | 0,00 % | Mountain Valley MD Holdings Inc: Mountain Valley appoints Batchelor as director | ||
| VERU | 2,310 | -2,53 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| ONTRAK | 0,184 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 26.08.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 26.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 26.08.2025.ISIN NameAU0000006934 NEW... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027 | All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T programAcquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR- Antagonist, Phase 3-ready) and TPST-1495... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 2,187 | +1,96 % | Clover Health Investments, Corp.: Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service | WILMINGTON, Del., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover," "Clover Health" or the "Company") today announced that Chelsea Clinton, the longest-serving... ► Artikel lesen |